SHENZHEN, China, August 8, 2022 /PRNewswire/ — BGI headed Asia and the Pacific and China ranking table for life sciences corporate institutions for the seventh consecutive year published in the Nature Index Annual Tables 2022. With a 19 percent increase in its adjusted share metric, BGI ranked eighth among global corporate institutions in life science field, an improvement over the previous year’s tenth-place result.
The nature index is an indicator of the effectiveness of institutional research. Share—the key Nature Index metric—is a fractional number per article assigned to an institution that accounts for the proportion of authors of the article from that institution.
Among the top ten corporate life science institutions in the world, there are six institutions from the US such as Pfizer, three from Europe such as Roche, with BGI as the only institution from APAC and China on this list.
BGI’s key research highlights from 2021 include:
- Zhou, Yang et al. “Platypus and echidna genomes reveal mammalian biology and evolution.” Nature NewsNature Publishing Group, January 6, 2021.
- Bi, Xupeng, etc. “Tracing the genetic imprints of vertebrate landings in non-teleost ray-finned fishes.” cell, flight 184, no. 5, 2021
- Wei, Tong et al. “Whole Genome Resequencing of 445 Lactuca Specimens Reveals the Domestication History of Cultivated Lettuce.” Natural genetics, vol. 53, no. 5, 2021, pp. 752–760.
- Yang, Chentao, et al. “Evolutionary and biomedical insights from a marmoset diploid genome assembly.” Nature, vol. 594, no. 7862, 2021, pp. 227–233.
- Xiang, Xi et al. “Improving CRISPR-Cas9 Grna Performance Prediction Using Data Integration and Deep Learning.” Nature Communications, flight 12, no. 1, 2021
- Varshney, RK, Roorkiwal, M., Sun, S. and others. “A map of chickpea genetic variation based on the sequencing of 3366 genomes.”Nature 599, 622–627 (2021).
BGI is “born global” as it is established September 9, 1999 by a group of young scientists to participate in the Global Human Genome Project and Implementation of China mission to sequence about 1% of the entire human genome. Since then, BGI research has often involved collaboration with various global institutions.
BGI currently leads international research projects such as the Ten Thousand Plant Genome Project and the Ten Thousand Bird Genome Project to sequence the genomes of 10,000 plants and birds respectively. BGI is also active in clinical research collaborations involving gene tests with high specificity and sensitivity.
About Nature Index
The Nature Index was first published in November 2005. The Count and Share metrics used to rank the Nature Index listings are based on an institution’s publications in 82 natural science journals selected on the basis of reputation by an independent panel of leading scientists in their fields. The Nature Index provides absolute numbers and fractional shares of article publication at the institutional and national level, and as such is an indicator of global high-quality research output and collaboration.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen China, is a leading global provider of genome sequencing and proteomic services. We enable scientists and researchers to reach their full potential by providing fully integrated genomic sequencing, proteomic services and high-quality solutions across a range of applications. Our services cover more than 100 countries and regions, including more than 2,300 medical institutions.
SOURCE BGI Genomics